Nu Skin Enterprises, Inc. (NUS) Receives $60.67 Average PT from Brokerages

Nu Skin Enterprises, Inc. (NYSE:NUS) has received an average recommendation of “Hold” from the ten analysts that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, three have given a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $60.67.

A number of analysts have recently issued reports on NUS shares. Stifel Nicolaus set a $50.00 price objective on shares of Nu Skin Enterprises and gave the company a “sell” rating in a research note on Thursday, August 3rd. Pivotal Research reiterated a “buy” rating and set a $80.00 price objective (up previously from $65.00) on shares of Nu Skin Enterprises in a research note on Thursday, June 22nd. Deutsche Bank AG lifted their price objective on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a research note on Wednesday, June 21st. Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating in a research note on Wednesday, July 5th. Finally, Bank of America Corporation lifted their price objective on shares of Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a research note on Monday, July 10th.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Wednesday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.08. The company had revenue of $550.10 million for the quarter, compared to analyst estimates of $548.09 million. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. The business’s quarterly revenue was down 8.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.79 earnings per share.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 13th. Investors of record on Friday, August 25th were paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date of this dividend was Wednesday, August 23rd. Nu Skin Enterprises’s dividend payout ratio is currently 48.81%.

In related news, President Ryan S. Napierski sold 8,000 shares of Nu Skin Enterprises stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $65.00, for a total transaction of $520,000.00. Following the sale, the president now directly owns 68,170 shares in the company, valued at $4,431,050. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Daniel W. Campbell sold 4,607 shares of Nu Skin Enterprises stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $62.48, for a total transaction of $287,845.36. Following the sale, the director now owns 63,753 shares in the company, valued at $3,983,287.44. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 27,040 shares of company stock worth $1,708,157. Company insiders own 5.20% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Wasatch Advisors Inc. raised its stake in shares of Nu Skin Enterprises by 3.4% during the second quarter. Wasatch Advisors Inc. now owns 638,396 shares of the company’s stock valued at $40,117,000 after purchasing an additional 20,957 shares in the last quarter. Ameritas Investment Partners Inc. raised its stake in shares of Nu Skin Enterprises by 2.0% during the second quarter. Ameritas Investment Partners Inc. now owns 14,864 shares of the company’s stock valued at $934,000 after purchasing an additional 297 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of Nu Skin Enterprises by 2.2% during the second quarter. The Manufacturers Life Insurance Company now owns 73,141 shares of the company’s stock valued at $4,596,000 after purchasing an additional 1,581 shares in the last quarter. Cubist Systematic Strategies LLC bought a new stake in shares of Nu Skin Enterprises during the second quarter valued at about $573,000. Finally, BlueCrest Capital Management Ltd bought a new stake in shares of Nu Skin Enterprises during the second quarter valued at about $897,000. Institutional investors and hedge funds own 79.25% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Nu Skin Enterprises, Inc. (NUS) Receives $60.67 Average PT from Brokerages” was first published by Transcript Daily and is owned by of Transcript Daily. If you are reading this news story on another domain, it was copied illegally and republished in violation of US and international copyright law. The legal version of this news story can be accessed at https://transcriptdaily.com/2017/10/13/nu-skin-enterprises-inc-nus-receives-60-67-average-pt-from-brokerages.html.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply